ALGN— ALIGN TECHNOLOGY INC

Health Care$12.5B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net revenues	$4.03B+0.9%	$4.00B+3.5%	$3.86B+3.4%	$3.73B
Cost of net revenues	$1.32B+10.3%	$1.20B+3.8%	$1.16B+5.0%	$1.10B
Gross profit	$2.71B-3.1%	$2.80B+3.4%	$2.71B+2.8%	$2.63B
Selling, general and administrative	$1.76B-0.4%	$1.76B+3.5%	$1.70B+1.7%	$1.67B
Research and development	$369.9M+1.6%	$364.2M+5.0%	$346.8M+13.6%	$305.3M
Restructuring and other charges	$35.4M+6.7%	$33.2M+149.1%	$13.3M+16.3%	$11.5M
Legal settlement loss	$4.2M-86.5%	$31.0M	$0	$0
Total operating expenses	$2.17B-1.2%	$2.19B+6.2%	$2.06B+3.6%	$1.99B
Income from operations	$545.8M-10.2%	$607.6M-5.6%	$643.3M+0.1%	$642.6M
Interest income	$16.0M-20.6%	$20.2M+17.2%	$17.3M+221.6%	$5.4M
Other income (expense), net	$23.5M+224.4%	-$18.9M+2.6%	-$19.4M+60.3%	-$48.9M
Total interest income and other income (expense), net	$39.5M+2870.1%	$1.3M+162.4%	-$2.1M+95.1%	-$43.5M
Net income before provision for income taxes	$585.3M-3.9%	$609.0M-5.0%	$641.2M+7.0%	$599.1M
Income Tax expense	$174.9M-6.7%	$187.6M-4.4%	$196.2M-17.4%	$237.5M
Net income	$410.4M-2.6%	$421.4M-5.3%	$445.1M+23.1%	$361.6M
Net income per share, basic (usd per share)	$5660.00+0.5%	$5630.00-3.3%	$5820.00+26.0%	$4620.00
Diluted (usd per share)	$5650.00+0.5%	$5620.00-3.3%	$5810.00+26.0%	$4610.00
Basic (shares)	$72.5M-3.1%	$74.9M-2.0%	$76.4M-2.3%	$78.2M
Diluted (shares)	$72.6M-3.2%	$75.0M-2.1%	$76.6M-2.4%	$78.4M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.